Revvity | PKI - 应收帐款人

股票价格
85.76
每天变化
0.83 0.98%
每月一次
-14.52%
每年
-19.84%
Q1 预测
82.99


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 10.48B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


应收帐款人 更改 日
Agilent USD 1.52B 34M 2025-12
Align Technology USD 1.1B 2.38M 2025-12
Bio Techne USD 184.61M 717K 2025-12
Bio-Rad Laboratories USD 464.7M 5.2M 2025-09
Bruker USD 544.9M 6M 2025-12
Celltrion KRW 1.51T 128.69B 2025-09
Charles River Laboratories USD 1.43B 54.59M 2025-12
Cspc Pharmaceutical CNY 8.85B 769.12M 2025-06
Danaher USD 3.91B 762M 2025-12
Dentsply International USD 688M 34M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Edwards Lifesciences USD 892.8M 9.8M 2025-09
Exact Sciences USD 306.05M 47.28M 2025-09
Hologic USD 584.2M 16.6M 2025-12
Illumina USD 854M 125M 2025-12
Intuitive Surgical USD 1.53B 267.6M 2025-12
IQVIA Holdings USD 3.43B 113M 2025-12
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Laboratory Of America USD 2.26B 4.5M 2025-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Mesa Laboratories USD 40.23M 4.66M 2024-09
Mettler Toledo International USD 778.24M 90.98M 2025-12
Myriad Genetics USD 115.3M 2.7M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
OraSure Technologies USD 22.2M 2.1M 2025-12
Organigram Holdings CAD 64.86M 7.31M 2025-09
Ovoca Bio EUR 447K 113K 2022-06
Pacific Biosciences Of California USD 35.45M 4.83M 2025-12
Pharma Mar EUR 60.6M 18.83M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Quest Diagnostics USD 1.41B 48M 2025-12
Quidel USD 417M 30.5M 2025-12
Repligen USD 158.59M 9.62M 2025-12
Revvity USD 744.67M 64.41M 2025-12
Sartorius EUR 344.7M 48.5M 2025-09
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Thermo Fisher Scientific USD 8.9B 11M 2025-12
Tilray USD 121.49M 18.12M 2025-03
Waters USD 828.84M 80.32M 2025-12
Zz Pientze Pharmaceu CNY 1.12B 222.78M 2025-09